Background: Ovarian germ cell tumors have low incidence and are responsible for about 20% of ovarian tumors. The current study aimed to analyze the clinicopathological features and treatment outcomes and subsequent fertility outcomes in patients with ovarian germ cell tumors and to increase awareness of this condition. Material and Methods: This is a retrospective descriptive study on ovarian germ cell tumor patients treated in Alzahra Hospital, the teaching and tertiary referral hospital in Tabriz, between 2011 to 2022. Results: 37 patients with ovarian germ cell tumors were identified. The mean age of the patients was 23.92 years old, and the most common chief complaint was abdominal pain. 90.32% of patients were diagnosed with stage I neoplasm. None of the patients had bilateral ovary involvement, and tumor recurrence was reported in 7.9% of patients. 71.1% of patients underwent adjuvant chemotherapy, and 86.84% of patients did not use assisted reproductive technology for fertility. From the histopathological point of view, dysgerminoma was the most commonly diagnosed ovarian germ cell tumor (36.8%). In our patients, the most commonly elevated tumor markers were LDH and AFP (39.47%). Conclusion: Ovarian germ cell tumors patients have an excellent prognosis, and the current treatment with surgery and adjuvant chemotherapy does not substantially affect their fertility.